A new bioresorbable device small enough to be delivered by injection could be a breakthrough in temporary pacemaker ...

A physician at Bassett Medical Center is one of the first in the region to successfully implant a new extravascular defibrillator. According to a Bassett news release, the device is designed to treat ...

Having already received a recommendation for inpatients from the CMS, EBR is now applying for reimbursement for its WISE CRT ...

Camgenium and Cardiac Tech have developed a solution to adverse events caused by current temporary pacing methods in ...

Camgenium, a Cambridge medical software engineering company, is partnering with MedTech innovator Cardiac Tech to develop and ...

Despite the positive results, there are open questions about LBB pacing, including long-term lead performance. RCTs are ...

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

Dr. Eric Rytkin discusses the clinical need for—and significant advantages of—his team’s recently unveiled millimeter-scale, ...

The choice between ICD types still should be based on each individual patient’s risk factors, Kenneth Ellenbogen says.

A system hybridizing cardiac contractility modulation and implantable cardioverter defibrillation successfully converted ...

Abbott today announced data from an acute clinical feasibility study of its Aveir Conduction System Pacing (CSP) system.

The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for ...